Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter Study of [18F]APN-1607 Positron Emission Tomography in Subjects With Alzheimer's Disease Compared to Healthy Subjects

NCT04141150 is registered in ClinicalTrials.gov with APRINOIA Therapeutics, LLC as lead sponsor.

NCT NCT04141150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter Study of [18F]APN-1607 Positron Emission Tomography in Subjects With Alzheimer's Disease Compared to Healthy Subjects
Lead sponsor
APRINOIA Therapeutics, LLC
Phase
Phase 2
Overall status
Unknown status
Start date
March 22, 2022
Completion date
February 28, 2025
Enrollment
130 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, healthy volunteers, mild cognitive impairment due to alzheimer's disease